Harvard Bioscience, Inc.

Harvard Bioscience, Inc.verified

HBIO

Price:

$0.7229

Market Cap:

$32.21M

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ-based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. It also engages in the development and m...[Read more]

Industry

Medical - Instruments & Supplies

IPO Date

2001-03-19

Stock Exchange

NASDAQ

Ticker

HBIO

The Enterprise Value as of December 2025 (TTM) for Harvard Bioscience, Inc. (HBIO) is 68.08M

According to Harvard Bioscience, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 68.08M. This represents a change of -33.62% compared to the average of 102.56M of the last 4 quarters.

Harvard Bioscience, Inc. (HBIO) Historical Enterprise Value (quarterly & annually)

How has HBIO Enterprise Value performed in the past?

The mean historical Enterprise Value of Harvard Bioscience, Inc. over the last ten years is 179.62M. The current 68.08M Enterprise Value has changed 3.69% with respect to the historical average. Over the past ten years (40 quarters), HBIO's Enterprise Value was at its highest in in the June 2021 quarter at 380.40M. The Enterprise Value was at its lowest in in the June 2025 quarter at 55.53M.

Quarterly (TTM)
Annual

Average

179.62M

Median

162.63M

Minimum

112.50M

Maximum

333.56M

Harvard Bioscience, Inc. (HBIO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Harvard Bioscience, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 61.41%

Maximum Annual Enterprise Value = 333.56M

Minimum Annual Increase = -50.70%

Minimum Annual Enterprise Value = 112.50M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024132.25M-50.18%
2023265.44M61.41%
2022164.45M-50.70%
2021333.56M55.11%
2020215.05M33.72%
2019160.81M-3.44%
2018166.55M42.48%
2017116.89M3.91%
2016112.50M-12.61%
2015128.72M-32.15%

Harvard Bioscience, Inc. (HBIO) Average Enterprise Value

How has HBIO Enterprise Value performed in the past?

The current Enterprise Value of Harvard Bioscience, Inc. (HBIO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

187.38M

5-year avg

222.15M

10-year avg

179.62M

Harvard Bioscience, Inc. (HBIO) Enterprise Value vs. Peers

How is HBIO’s Enterprise Value compared to its peers?

Harvard Bioscience, Inc.’s Enterprise Value is greater than NEXGEL, Inc. (19.40M), greater than Retractable Technologies, Inc. (21.31M), greater than Femasys Inc. (34.66M), greater than Nexalin Technology, Inc. (17.37M), greater than Sonnet BioTherapeutics Holdings, Inc. (8.18M), greater than TAO Synergies Inc. (8.89M), greater than NuCana plc (11.88M), greater than Cosmos Health Inc. (26.10M), greater than CollPlant Biotechnologies Ltd. (21.10M),

Build a custom stock screener for Harvard Bioscience, Inc. (HBIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Harvard Bioscience, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Harvard Bioscience, Inc. (HBIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Harvard Bioscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Harvard Bioscience, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Harvard Bioscience, Inc. (HBIO)?

What is the 3-year average Enterprise Value for Harvard Bioscience, Inc. (HBIO)?

What is the 5-year average Enterprise Value for Harvard Bioscience, Inc. (HBIO)?

How does the current Enterprise Value for Harvard Bioscience, Inc. (HBIO) compare to its historical average?